[ESPR] YoY Annual Result on 31-Dec-2015 [#FY]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
25-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#FY]
Profit Trend
YoY- -36.86%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Annual Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 184,474 0 0 0 0 4,977,012 0 -
PBT -201,810 -166,988 -74,978 -49,784 -36,375 -26,088 -11,742 60.61%
Tax 2,875 2,132 1,672 1,060 229 1,131 1,403 12.69%
NP -201,810 -166,988 -74,978 -49,784 -36,375 -26,088 -11,742 60.61%
Tax Rate - - - - - - - -
Total Cost 386,284 166,988 74,978 49,784 36,375 5,003,100 11,742 78.95%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -109.40 0.00 0.00 0.00 0.00 -0.52 0.00 -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -7.54 -6.98 -3.33 -2.26 -2.22 -1.71 -1.22 35.44%
EPS Diluted -7.54 -6.98 -3.33 -2.26 -2.22 -1.70 -1.22 35.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.